Stryker Corporation is facing an increasing number of hip replacement lawsuits alleging that the company’s implants were defective and caused injuries. More than 500 Stryker lawsuits allege that the metal components of the Rejuvenate and ABG II modular hip replacements can lead to corrosion, fretting and other severe complications.
The Stryker Rejuvenate and Stryker ABG II hip replacements were approved through the Food and Drug Administration’s 510(K) approval process, which allowed the products to be sold without significant clinical testing. After thousands of complaints, Stryker issued a hip replacement recall for the Rejuvenate and ABG II implants in July 2012.
Stryker hip replacements could potentially lead to serious complications, including metal poisoning caused by toxic levels of cobalt and chromium in the blood stream. Other Stryker side effects include fretting, corrosion, pain, swelling, limited mobility and tissue damage, which could require revision surgery.